Skip to main content
Top
Published in: Rheumatology International 10/2013

01-10-2013 | Original Article

Validation of an Adapted Arabic Version of Fibromyalgia Syndrome Impact Questionnaire

Authors: Mai Abd El-Naby, Mohamed Ahmed Hefny, Ayman Ekram Fahim, Magdy Ahmed Awadalla

Published in: Rheumatology International | Issue 10/2013

Login to get access

Abstract

Fibromyalgia (FM) is the most common chronic pain syndrome encountered in medical practice, affecting females more than males, and the estimated prevalence of FM in Egypt is 1.3 %. The aim was to translate and adapt the Fibromyalgia Impact Questionnaire (FIQ) into Arabic and assess reliability and validity. The Arabic version of Fibromyalgia Impact Questionnaire (FIQ-A) was adapted following the forward/backward translation approach. Fifty-one female patients with FM were studied to assess psychometric properties of the FIQ-A. Reliability was analyzed by the correlation coefficient between test and retest. Internal consistency was checked by the Cronbach’s alpha coefficient. Construct validity was assessed comparing FIQ-A with Health Assessment Questionnaire (HAQ), Health Assessment Questionnaire of Fibromyalgia (FHAQ), The Medical Outcome Survey Short-Form-36 (SF-36), and the Total Visual Analog Scale (TVAS) for FM symptom, and feasibility was assessed by the time taken in completing the FIQ-A and the proportion of patients completed the questionnaire. Patients studied were 33.2 ± 9.8 years old. Translation was concordant. Adaptation affected 4 sub-items of physical function. Test–retest correlation coefficient was 0.89 for total FIQ-A and Cronbach’s alpha was 0.76. Excellent to good statistically significant correlations (p < 0.05) were found between the FIQ-A items and HAQ, FHAQ, and SF-36. The FIQ-A is a reliable, valid for measuring health status and physical function in Arabic-speaking FM patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Perrot S, Dickenson AH, Bennett RM (2008) Fibromyalgia: harmonizing science with clinical practice considerations. Pain Pract 8:177–189 Perrot S, Dickenson AH, Bennett RM (2008) Fibromyalgia: harmonizing science with clinical practice considerations. Pain Pract 8:177–189
3.
go back to reference Abdel-Tawab RR, Abdel-Nasser AM, Darmawan J et al. (2004) The prevalence of rheumatic diseases in rural Egypt: COPCORD-Egypt: Abstract, 11th APLAR Congress, Jeju, Korea Abdel-Tawab RR, Abdel-Nasser AM, Darmawan J et al. (2004) The prevalence of rheumatic diseases in rural Egypt: COPCORD-Egypt: Abstract, 11th APLAR Congress, Jeju, Korea
4.
go back to reference Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172CrossRefPubMed Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172CrossRefPubMed
5.
go back to reference Clauw DJ, Crofford LJ (2003) Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 17:685–701CrossRefPubMed Clauw DJ, Crofford LJ (2003) Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 17:685–701CrossRefPubMed
6.
go back to reference Dadabhoy D, Clauw DJ (2006) Therapy insight: fibromyalgia: a different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol 2:364–372CrossRefPubMed Dadabhoy D, Clauw DJ (2006) Therapy insight: fibromyalgia: a different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol 2:364–372CrossRefPubMed
7.
go back to reference Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L et al (2008) Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 73:114–120CrossRefPubMed Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L et al (2008) Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 73:114–120CrossRefPubMed
8.
go back to reference Mohammed RH, ElMakhzangy HI, Gamal A, Mekky F, El Kassas M, Mohammed N, Abdel Hamid M, Esmat G (2010) Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians. Clin Rheumatol 29:1373–1380CrossRefPubMed Mohammed RH, ElMakhzangy HI, Gamal A, Mekky F, El Kassas M, Mohammed N, Abdel Hamid M, Esmat G (2010) Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians. Clin Rheumatol 29:1373–1380CrossRefPubMed
9.
go back to reference Hefny M, Fada, SM, El Hadidi KT, Awadalla MA et al (1997) Relative frequency of fibromyalgia among Suez Canal university students with benign joint hyper-mobility syndrome. www.srv3.eulc.edu.eg Hefny M, Fada, SM, El Hadidi KT, Awadalla MA et al (1997) Relative frequency of fibromyalgia among Suez Canal university students with benign joint hyper-mobility syndrome. www.​srv3.​eulc.​edu.​eg
10.
go back to reference Hoffman DL, Dukes EM (2008) The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract 62:115–126CrossRefPubMed Hoffman DL, Dukes EM (2008) The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract 62:115–126CrossRefPubMed
11.
go back to reference Burckhardt CS, Clark SR, Bennett RM (1991) The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 18:728–733PubMed Burckhardt CS, Clark SR, Bennett RM (1991) The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 18:728–733PubMed
12.
go back to reference Bennett R (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23:S154–S162PubMed Bennett R (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23:S154–S162PubMed
13.
go back to reference Martine LG, Mainguyd Y, Katell LL, Nadjard A, Delphine AB, Martine G (2010) Linguistic validation of six patient-reported outcomes instruments into 12 languages for patients with fibromyalgia. Jt Bone Spine 77:165–170CrossRef Martine LG, Mainguyd Y, Katell LL, Nadjard A, Delphine AB, Martine G (2010) Linguistic validation of six patient-reported outcomes instruments into 12 languages for patients with fibromyalgia. Jt Bone Spine 77:165–170CrossRef
14.
go back to reference Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle A (1994) A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 21:714–720PubMed Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle A (1994) A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 21:714–720PubMed
15.
go back to reference El Meidany Y, El Gaafary M, Ahmed I (2003) Cross-cultural adaptation and validation of an Arabic Health Assessment Questionnaire for use in Rheumatoid arthritis patients. Jt Bone Spine 70:195–202CrossRef El Meidany Y, El Gaafary M, Ahmed I (2003) Cross-cultural adaptation and validation of an Arabic Health Assessment Questionnaire for use in Rheumatoid arthritis patients. Jt Bone Spine 70:195–202CrossRef
16.
go back to reference Wolfe F, Hawley DJ, Goldenberg DL, Russel IJ, Buskila D, Neumann L (2000) The assessment of functional impairment in fibromyalgia: Rasch analyses of 5 functional scales and the development of the Fibromyalgia Health Assessment Questionnaire. J Rheumatol 27:1989–1999PubMed Wolfe F, Hawley DJ, Goldenberg DL, Russel IJ, Buskila D, Neumann L (2000) The assessment of functional impairment in fibromyalgia: Rasch analyses of 5 functional scales and the development of the Fibromyalgia Health Assessment Questionnaire. J Rheumatol 27:1989–1999PubMed
17.
go back to reference Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care 30(6):473–483CrossRefPubMed Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care 30(6):473–483CrossRefPubMed
18.
go back to reference Al abdulmohsin S, Joel S, Draugalis J (1997) Translation of RAND 36-item health survey 1.0 into Arabic; University of Arizona center for pharmaceutical economics Al abdulmohsin S, Joel S, Draugalis J (1997) Translation of RAND 36-item health survey 1.0 into Arabic; University of Arizona center for pharmaceutical economics
19.
go back to reference Streiner DL, Norman GR (2003) Health measurement scales, 3rd edn. Oxford University Press, New York Streiner DL, Norman GR (2003) Health measurement scales, 3rd edn. Oxford University Press, New York
20.
go back to reference Offenbaecher M, Waltz M, Schoeps P (2000) Validation of a German Version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol 27:823–845 Offenbaecher M, Waltz M, Schoeps P (2000) Validation of a German Version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol 27:823–845
21.
go back to reference Kim Y, Lee S, Park K (2002) Validation of a Korean version of the Fibromyalgia Impact Questionnaire. J Korean Med Sci 17:220–224PubMed Kim Y, Lee S, Park K (2002) Validation of a Korean version of the Fibromyalgia Impact Questionnaire. J Korean Med Sci 17:220–224PubMed
22.
go back to reference Osada K, Oka H, Isomura T, Nakamura I, Tominaga K, Takahashi S, Kojima A, Nishioka K (2001) Development of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ): psychometric assessments of reliability and validity. Int J Rheum Dis 14:74–80CrossRef Osada K, Oka H, Isomura T, Nakamura I, Tominaga K, Takahashi S, Kojima A, Nishioka K (2001) Development of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ): psychometric assessments of reliability and validity. Int J Rheum Dis 14:74–80CrossRef
23.
go back to reference Rivara J, Gonzalez T (2004) The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 22:554–560 Rivara J, Gonzalez T (2004) The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 22:554–560
24.
go back to reference Bae SC, Lee JH (2004) Cross-cultural adaptation and validation of the Korean Fibromyalgia Impact Questionnaire in women patients with fibromyalgia for clinical research. Qual Life Res 13:857–861CrossRefPubMed Bae SC, Lee JH (2004) Cross-cultural adaptation and validation of the Korean Fibromyalgia Impact Questionnaire in women patients with fibromyalgia for clinical research. Qual Life Res 13:857–861CrossRefPubMed
25.
go back to reference Zljlstra TR, Taal E, VandeLaar MA, Rasker JJ (2007) Validation of a Dutch translation of the Fibromyalgia Impact Questionnaire. Rheumatology (Oxford) 46:131–134CrossRef Zljlstra TR, Taal E, VandeLaar MA, Rasker JJ (2007) Validation of a Dutch translation of the Fibromyalgia Impact Questionnaire. Rheumatology (Oxford) 46:131–134CrossRef
26.
go back to reference Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12CrossRefPubMed Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12CrossRefPubMed
Metadata
Title
Validation of an Adapted Arabic Version of Fibromyalgia Syndrome Impact Questionnaire
Authors
Mai Abd El-Naby
Mohamed Ahmed Hefny
Ayman Ekram Fahim
Magdy Ahmed Awadalla
Publication date
01-10-2013
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 10/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2779-z

Other articles of this Issue 10/2013

Rheumatology International 10/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.